Sante Nutraceuticals Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
- Paid Up Capital ₹ 5.34 Cr
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 8.00 Cr
- Revenue Growth -30.75%
- Profit Growth -102.11%
- Ebitda -32.11%
- Net Worth -0.03%
- Total Assets -2.54%
About Sante Nutraceuticals
Sante Nutraceuticals Private Limited (SNPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 November 2013 and has a history of 11 years and two months. Its registered office is in Gautam Buddha Nagar, Uttar Pradesh, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 5.34 Cr.
The company has closed loans amounting to ₹8.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Aastha Setia and Mahasweta Sahoo serve as directors at the Company.
Company Details
-
Location
Gautam Buddha Nagar, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U15400UP2013PTC123989
-
Company No.
123989
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
13 Nov 2013
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Sante Nutraceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aastha Setia
|
Director | 05-Mar-2019 | Current |
|
Mahasweta Sahoo
|
Director | 14-Mar-2022 | Current |
Financial Performance of Sante Nutraceuticals.
Sante Nutraceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 30.75% decrease. The company also saw a substantial fall in profitability, with a 102.11% decrease in profit. The company's net worth dipped by a decrease of 0.03%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sante Nutraceuticals?
In 2023, Sante Nutraceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Medifuture Pharmaceuticals Private LimitedAastha Setia is a mutual person
Charges (Loans)
₹0
₹8.00 Cr
Charges Breakdown by Lending Institutions
- Bank Of Baroda : 8.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Aug 2015 | Bank Of Baroda | ₹2.00 Cr | Satisfied |
| 04 Aug 2015 | Bank Of Baroda | ₹6.00 Cr | Satisfied |
How Many Employees Work at Sante Nutraceuticals?
Unlock and access historical data on people associated with Sante Nutraceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sante Nutraceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sante Nutraceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
